Metabolic outcomes from comparative studies mirror these mechanisms
Data from a phase II trial supports these assertions, with an average body weight loss of 24.2% over 48 weeks in obese subjects
Development was ultimately discontinued after clinical results did not demonstrate sufficient efficacy to meet pharmaceutical thresholds
Sekhars years-long expertise, knowledge and interest in metabolic disorders affecting HIV patients and a parallel track investigating non-HIV people have resulted in the publication of significant discoveries regarding the metabolic complications in aging, HIV and diabetes, and has guided numerous clinical trials that together provide a better understanding of why we age
Address correspondence to: Hariom Yadav, 575 Patterson Avenue, Suite 2E-034, Biotech Place, Downtown, Department of Internal Medicine-Molecular Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina 27101, USA